Instituto de Investigación Marqués de Valdecilla — CureCurrent

Published trials22

Recruiting shown2

Roles2

SourceClinicalTrials.gov

Clinical trials

22 shown

Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)NCT07611747 · lead sponsor · 2026-04-22

TO ASSESS THE EFFECTIVENESS OF THE INTERVENTION OF THE LOW-SODIUM DIET IN PATIENTS WITH HTANCT04677322 · lead sponsor · 2020-09-01

Efficacy and Safety of Endoscopic Sleeve Gastroplasty Versus Laparoscopic Sleeve Gastrectomy in Obese Subjects With NASHNCT04060368 · lead sponsor · 2020-06-01

Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET)NCT04350216 · lead sponsor · 2020-04-30

Endoscopic Bariatric Therapy in NASH CirrhosisNCT04281303 · lead sponsor · 2020-04-01

Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)NCT04191044 · lead sponsor · 2020-01-10

Determining Efficacy of an Artificial Intelligence-based System for Heart Failure Detection Through Interpretation of Electrocardiograms (DECISION)NCT07113223 · collaborator · 2025-07-23

Early Detection of Respiratory Disorders in PsychosisNCT03476473 · collaborator · 2018-02-16

Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective PsychosisNCT03481465 · collaborator · 2018-02-12

Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia PatientsNCT02897167 · collaborator · 2016-08-01

Impact of Aerobic Exercise on Metabolic Syndrome, Neurocognition and Empowerment in Individuals With Mental DisordersNCT02858102 · collaborator · 2016-06-01

Cost-effectiveness of Interventions in First-episode PsychosisNCT02916303 · collaborator · 2016-06-01

Novel Candidate Genes for Treatment Response to Antipsychotics in SchizophreniaNCT02205437 · collaborator · 2015-01-01

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 3-years Follow-upNCT03883204 · collaborator · 2015-01-01

Longitudinal Long-term Study (10 Years) of the Sample of First Episode of Non-affective Psychosis: PAFIPNCT02200588 · collaborator · 2014-09-01

10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsNCT03090490 · collaborator · 2014-09-01

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 3-year Follow-upNCT03090503 · collaborator · 2014-06-01

Effectiveness of Second Generation Antipsychotics in First Episode Psychosis Patients: 1-year Follow-upNCT02532491 · collaborator · 2014-05-01

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in Treatment of First Episode Psychosis: 3-year Follow-upNCT02526030 · collaborator · 2008-10-01

Comparative Study of Aripiprazole, Quetiapine and Ziprasidone in the Treatment of First Episode Nonaffective PsychosisNCT02305823 · collaborator · 2005-10-01

Neurocognitive Effectiveness in Treatment of First-episode Non-affective Psychosis: 1-year Follow-upNCT02534363 · collaborator · 2005-10-01

3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsNCT02220504 · collaborator · 2004-07-01

Sponsor roles

collaborator16

lead sponsor6

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.